Literature DB >> 24831244

Expression of HPV-16 E6 protein and p53 inactivation increases the uterine cervical cancer invasion.

X Yang1, L Lu2.   

Abstract

INTRODUCTION: Human papillomavirus infection (HPV-16) and expression of HPV E6 protein are the major risk factors of cervical cancer. Studies reported that expression of E6 protein adversely affect the function of p53 and thus involved in tumor progression. In the present study, we made an attempt to analyze the prevalence of HPV-16 association, E6 and p53 expression in cervical cancer tissues.
METHODS: Uterine cervical cancer (n=10) and corresponding normal epithelium tissues (n=10) were collected at the time of surgery. The HPV-16 integration and E6 expression were analyzed by PCR and immunohistostaining. Further, p53 and Ki67 expression were analyzed by immunohistostaining. Telomerase was detected using a modified TRAP (telomerase repeat amplification protocol) assay.
RESULTS: We have found that almost 90% of the collected cervical cancer DNA samples showed positivity to HPV-16 and more than 60% of DNA samples were E6 positive. Further, these tissues were highly positive to p53 and Ki67 protein which contribute to apoptosis resistance and increased cell proliferation. We also found elevated level of telomerase expression in cancer tissues compared to control.
CONCLUSIONS: The association of HPV infection and E6 expression increases the risk of cervical cancer. Further, E6 expression is the cause for inactivation of p53 in tumor tissues and deregulated cell proliferation and thus favors for tumor invasion. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24831244     DOI: 10.1055/s-0034-1372614

Source DB:  PubMed          Journal:  Drug Res (Stuttg)        ISSN: 2194-9379


  6 in total

1.  Effect of FHIT loss and p53 mutation on HPV-infected lung carcinoma development.

Authors:  Yan Yu; Xiaofei Liu; Yuxuan Yang; Xiaodan Zhao; Jianjun Xue; Weixiao Zhang; Aimin Yang
Journal:  Oncol Lett       Date:  2015-05-15       Impact factor: 2.967

Review 2.  Mechanistic and Technical Challenges in Studying the Human Microbiome and Cancer Epidemiology.

Authors:  Mukesh Verma
Journal:  Technol Cancer Res Treat       Date:  2016-06-22

Review 3.  The role of TLRs in cervical cancer with HPV infection: a review.

Authors:  Xiao Yang; Yanxiang Cheng; Chunsheng Li
Journal:  Signal Transduct Target Ther       Date:  2017-11-03

4.  Efficacy of recombinant human adenovirus-p53 combined with chemotherapy for locally advanced cervical cancer: A clinical trial.

Authors:  Jie Xiao; Jian Zhou; Min Fu; Li Liang; Qiaoling Deng; Xiaoyun Liu; Fumin Liu
Journal:  Oncol Lett       Date:  2017-03-24       Impact factor: 2.967

Review 5.  Profile of bevacizumab and its potential in the treatment of cervical cancer.

Authors:  Christine M Fisher; Tracey E Schefter
Journal:  Onco Targets Ther       Date:  2015-11-19       Impact factor: 4.147

6.  Expression of Yin Yang 1 in cervical cancer and its correlation with E-cadherin expression and HPV16 E6.

Authors:  Wanxue Wang; Zhenni Yue; Zhengping Tian; Yiran Xie; Jiamiao Zhang; Yuanping She; Bing Yang; Yuan Ye; Yihua Yang
Journal:  PLoS One       Date:  2018-02-22       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.